MAPT and Alzheimer disease: The previous data demonstrated that neurotransmitter level (GABA and glutamate) and Aβ, and also hyperphosphorylated Tau protein, are not significantly altered in the brain cortex, hippocampus, and retina at an early stage in the experimental model of AD (3×Tg mouse model) [133].